Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-023939

President and CEO sold 707 shares at $9.15 ($6,469)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
AHMED NADIM President and CEO 2023-05-23 Sale −707 $9.15 $6,469 116,581 D: show line 1 in the form
Open-market sales · 707 sh · avg $9.15 · $6,469
Loading xslF345X04/ownership.xml…